Tetsuya Moritake

Seiwa Hospital

Papers

1

Total Citations

10

H-Index

1

About

Tetsuya Moritake is a leading figure in gynecologic oncology, with a focused research interest in optimizing surgical outcomes for early-stage endometrial cancer. His work critically examines the intersection of robotic surgery and oncological safety, particularly investigating the controversial role of uterine manipulators. In his most cited study (2022, 10 citations), Moritake conducted a comparative analysis of 86 robotic and 67 open surgeries, providing key evidence on whether manipulator use affects disease-free survival. This contribution addresses a vital clinical question, as the potential for tumor dissemination during minimally invasive procedures remains a concern. By systematically evaluating oncological outcomes, Moritake helps refine surgical protocols, balancing the benefits of robotic precision with the imperative of cancer control. His research is instrumental for surgeons navigating the adoption of robotic platforms, offering data-driven guidance to improve patient prognosis. Moritake’s work stands out for its direct impact on clinical practice, bridging the gap between technological innovation and evidence-based medicine.

Research Focus

Key Achievements

1
H-Index
1
Papers
10
Total Citations
10
Avg Citations/Paper
🏆 Most Cited Paper
Does the use of a uterine manipulator in robotic surgery for early‐stage endometrial cancer affect oncological outcomes?
10 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 2
🏛 Institutions: Seiwa Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago